BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 16950695)

  • 1. Quantitative assessment of iron-oxide-enhanced magnetic resonance imaging of the liver: Vessel isointensity is a potential characteristic of liver hemangiomas on late T1-weighted images.
    Schmitz SA; Nikolova A; O'Regan D; Albrecht T; Hohmann J; Wolf KJ
    Acta Radiol; 2006 Sep; 47(7):634-42. PubMed ID: 16950695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM; Kim CS; Youk JH; Lee MS
    Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions.
    Kumano S; Murakami T; Kim T; Hori M; Okada A; Sugiura T; Noguchi Y; Kawata S; Tomoda K; Nakamura H
    AJR Am J Roentgenol; 2003 Nov; 181(5):1335-9. PubMed ID: 14573430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227.
    Harisinghani MG; Saini S; Weissleder R; Halpern EF; Schima W; Rubin DL; Stillman AE; Sica GT; Small WC; Hahn PF
    Radiology; 1997 Mar; 202(3):687-91. PubMed ID: 9051017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
    Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R
    Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver.
    Arbab AS; Ichikawa T; Sou H; Araki T; Nakajima H; Ishigame K; Yoshikawa T; Kumagai H
    Radiology; 2002 Oct; 225(1):151-8. PubMed ID: 12354999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
    Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
    J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
    Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
    Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI].
    Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G
    Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal MR protocol for hepatic hemangiomas. Comparison of conventional spin-echo sequences with T2-weighted turbo spin-echo and serial gradient-echo (FLASH) sequences with gadolinium enhancement.
    Kim TK; Choi BI; Han JK; Jang HJ; Han MC
    Acta Radiol; 1997 Jul; 38(4 Pt 1):565-71. PubMed ID: 9240679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of AMI-25 on liver vessels and tumors on T1-weighted turbo-field-echo images: implications for tumor characterization.
    van Gansbeke D; Metens TM; Matos C; Nicaise N; Gay F; Raeymaekers H; Struyven J
    J Magn Reson Imaging; 1997; 7(3):482-9. PubMed ID: 9170031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
    Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY
    J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
    Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
    Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis between metastatic tumors and nonsolid benign lesions of the liver using ferucarbotran-enhanced MR imaging.
    Higashihara H; Murakami T; Kim T; Hori M; Onishi H; Nakata S; Osuga K; Tomoda K; Nakamura H
    Eur J Radiol; 2010 Jan; 73(1):125-30. PubMed ID: 19019608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of SPIO particles for characterization of liver hemangiomas using MRI.
    Montet X; Lazeyras F; Howarth N; Mentha G; Rubbia-Brandt L; Becker CD; Vallee JP; Terrier F
    Abdom Imaging; 2004; 29(1):60-70. PubMed ID: 15160755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hepatic VX2 carcinomas with ferucarbotran-enhanced magnetic resonance imaging in rabbits: Comparison of nine pulse sequences.
    Kim SH; Choi D; Lim HK; Kim MJ; Jang KM; Kim SH; Lee WJ; Lee J; Jeon YH; Lim JH
    Eur J Radiol; 2006 Sep; 59(3):413-23. PubMed ID: 16678373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.